Metraipolis › archive › dc_6ff4e64a19a1

Molecular mechanisms and clinical applications of gut microbiota-derived bioactive compounds in metabolic dysfunction-associated fatty liver disease — Europe PMC PMID:41190061

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41190061
DOI
10.3389/fimmu.2025.1682755
License (as archived)
solo-consultazione
Archived
2026-11-09T04:49:05.810Z
SHA-256 of the archived text
791e257e20536ce31d1e10c70a5a959ee231926baaef38f304a87745d8810c9b
Stable URL of this page
https://metraipolis.com/documento/dc_6ff4e64a19a1

How to cite

Molecular mechanisms and clinical applications of gut microbiota-derived bioactive compounds in metabolic dysfunction-associated fatty liver disease — Europe PMC PMID:41190061 — Europe PMC (en), https://europepmc.org/article/MED/41190061 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ff4e64a19a1 (Metraipolis archive dc_6ff4e64a19a1, sha256 791e257e20536ce31d1e10c70a5a959ee231926baaef38f304a87745d8810c9b)
BibTeX
@misc{dc6ff4e64a19a1,
  title = {Molecular mechanisms and clinical applications of gut microbiota-derived bioactive compounds in metabolic dysfunction-associated fatty liver disease — Europe PMC PMID:41190061},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41190061},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ff4e64a19a1; sha256 791e257e20536ce31d1e10c70a5a959ee231926baaef38f304a87745d8810c9b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41190061. Agents can read the archived copy with the MCP tool read_document.